Median Technologies to speak at the Radiological Society of North America 2023 Annual Meeting, Nov. 26 – 30, Chicago, IL, USA

Sophia-Antipolis, France

Press release – For immediate release – 5:45 pm CET

Median Technologies to speak at the Radiological Society of North America 2023 Annual Meeting, Nov. 26 – 30, Chicago, IL, USA

  • AI Theater Presentation: “Transforming Cancer Diagnosis through End-to-End AI-Powered SaMD”
  • Median’s teams will be at booth #4465, South Hall Level 3, to present the latest developments on iBiopsy® as well as the imaging CRO offering.

Median Technologies (ALMDT) announced today that the Company will be speaking and presenting at the world’s largest medical imaging conference, the Radiological Society of North America (RSNA) 2023 Annual Meeting and Scientific Assembly, being held in Chicago, IL, USA, Nov. 26-30, 2023.

The Company will give a presentation. Details of the session include:

Session: AI Theater

Presentation: Transforming Cancer Diagnosis through End-to-End AI-Powered SaMD

Date: November 26, 2023 – 1:00 pm – 1:15 pm CT

Place: South Hall Level 3, AI showcase theater

Median’s iBiopsy® and iCRO teams will be available at booth #4465, Level 3 South Hall (AI showcase) for the duration of the industry exhibition (Nov 26- 29, 10:00 am – 5:00 pm CT).

Download 20231122_PR_RSNA2023_EN.pdf

About Median Technologies

Pioneering in innovative imaging solutions and services, Median Technologies harnesses cutting-edge AI to elevate the accuracy of early cancer and metabolic disease diagnoses and treatments. Median’s offerings, including iCRO for medical image analysis and management in oncology trials and eyonis™, AI/ML tech-based suite of software as medical devices (SaMD), empower biopharmaceutical entities and clinicians to advance patient care and expedite novel therapies. Since its inception, the French-based company, with a presence in the U.S. and China, has been recognized as an “Innovative company” by BPI France and trades on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is eligible for the French SME equity savings plan scheme (PEA-PME).

 

Contacts

Median Technologies
Emmanuelle Leygues
Head of Corporate Marketing and Financial Communications
+33 6 10 93 58 88
emmanuelle.leygues@mediantechnologies.com

Press – ALIZE RP
Caroline Carmagnol
+33 6 64 18 99 59
median@alizerp.com

Investors – ACTIFIN
Ghislaine Gasparetto
+33 6 21 10 49 24
ggasparetto@actifin.fr